Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

STAA – STAAR Surgical Company

STAA — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

14.27

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

0.2

EPS Last/This Y

2.21

EPS This/Next Y

0.23

Price

21.1

Target Price

19.72

Analyst Recom

2.82

Performance Q

-11.9

Upside

-370.5%

Beta

0.94

Ticker: STAA




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09STAA18.341.731.0318920
2026-03-10STAA17.241.741.6218907
2026-03-11STAA17.681.741.9618988
2026-03-12STAA18.41.740.2019075
2026-03-13STAA18.391.740.2019075
2026-03-17STAA17.851.850.1819662
2026-03-18STAA18.581.871.0319581
2026-03-19STAA17.491.891.8419601
2026-03-20STAA17.511.301.5016041
2026-03-23STAA18.490.890.247761
2026-03-24STAA18.970.650.0910173
2026-03-25STAA19.20.540.8111842
2026-03-26STAA18.660.533.7311868
2026-03-27STAA17.910.584.6112338
2026-03-30STAA18.360.580.4612387
2026-03-31STAA18.70.580.6313190
2026-04-01STAA19.340.590.4513290
2026-04-02STAA20.240.591.3413311
2026-04-06STAA20.970.580.3113578
2026-04-07STAA21.080.581.0213896
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09STAA18.32113.9- 0.63
2026-03-10STAA17.24113.9- 0.63
2026-03-11STAA17.68113.9- 0.63
2026-03-12STAA18.41113.9- 0.63
2026-03-13STAA18.83107.2- 0.63
2026-03-17STAA17.83107.2- 0.63
2026-03-18STAA18.59107.2- 0.63
2026-03-19STAA17.49107.2- 0.63
2026-03-20STAA17.50107.2- 0.63
2026-03-23STAA18.50107.2- 0.63
2026-03-24STAA18.98107.2- 0.63
2026-03-25STAA19.20107.2- 0.63
2026-03-26STAA18.65107.2- 0.63
2026-03-27STAA17.91107.2- 0.63
2026-03-30STAA18.37107.4- 0.59
2026-03-31STAA18.70107.4- 0.59
2026-04-01STAA19.34107.4- 0.59
2026-04-02STAA20.21107.4- 0.59
2026-04-06STAA20.98107.4- 0.59
2026-04-07STAA21.10107.4- 0.59
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09STAA0-2.1511.66
2026-03-10STAA0-2.1511.66
2026-03-11STAA0-2.1512.66
2026-03-12STAA0-2.1512.66
2026-03-13STAA0-2.1512.66
2026-03-17STAA0-2.1312.66
2026-03-18STAA0-2.1312.66
2026-03-19STAA0-2.1312.66
2026-03-20STAA0-2.1312.66
2026-03-23STAA0-2.1312.66
2026-03-24STAA0-2.1312.66
2026-03-25STAA0-2.1314.27
2026-03-26STAA0-2.1314.27
2026-03-27STAA0-2.1314.27
2026-03-30STAA0-2.1214.27
2026-03-31STAA0-2.1214.27
2026-04-01STAA0-2.1214.27
2026-04-02STAA0-2.1214.27
2026-04-06STAA0-2.1214.27
2026-04-07STAA0-2.1214.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

0.07

Avg. EPS Est. Next Quarter

0.21

Insider Transactions

Institutional Transactions

-2.12

Beta

0.94

Average Sales Estimate Current Quarter

67

Average Sales Estimate Next Quarter

82

Fair Value

Quality Score

40

Growth Score

34

Sentiment Score

55

Actual DrawDown %

87.1

Max Drawdown 5-Year %

-90.7

Target Price

19.72

P/E

Forward P/E

32.37

PEG

P/S

4.36

P/B

3.03

P/Free Cash Flow

EPS

-1.63

Average EPS Est. Cur. Y​

0.59

EPS Next Y. (Est.)

0.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-33.6

Relative Volume

0.64

Return on Equity vs Sector %

-50.8

Return on Equity vs Industry %

-32.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.18

EBIT Estimation

STAA Healthcare
$21.09
📉
Swing / Pullback
Buy the dip on strong trends
46 /100
WEAK
Trend
18/20
Pullback
6/25
Volume
9/15
Valuation
9/20
TP/AR
0/10
Options
4/10
RSI
65.1
Range 1M
93%
Sup Dist
3.1%
🚀
Momentum Growth
Ride accelerating trends
46 /100
WEAK
Momentum
17/25
Growth
21/30
Estimates
1/20
Inst/Vol
1/15
Options
6/10
EPS Yr
140.9%
EPS NY
59.4%
52W%
40.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +23.9% upside
Quality
7/30
Valuation
8/30
Growth
17/25
Stability
8/10
LT Trend
1/5
Upside
+23.9%
Quality
40
STAAR Surgical Company
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 921
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAA

Latest News

Caricamento notizie per STAA
stock quote shares STAA – STAAR Surgical Company Stock Price stock today
news today STAA – STAAR Surgical Company stock forecast ,stock prediction 2023 2024 2025
marketwatch STAA – STAAR Surgical Company yahoo finance google finance
stock history STAA – STAAR Surgical Company invest stock market
stock prices STAA premarket after hours
ticker STAA fair value insiders trading